Dexcom's first-ever over-the-counter glucose monitor patch gets FDA clearance
Publishing timestamp: 2024-03-06 08:59:44
Summary
Dexcom's new over-the-counter continuous glucose monitor called Stelo has been cleared by FDA for use by Type 2 diabetes patients who do not use insulin. It will be available for purchase online in the summer of 2024, expanding access to CGMs without the need for a prescription. Shares of Dexcom rose more than 2% in extended trading following the announcement.
Sentiment: POSITIVE
Tickers: DXCM,
Keywords: health care industry, internet, technology, business news, breaking news: technology, dexcom inc, enterprise,
Source: https://www.cnbc.com/2024/03/05/dexcom-announces-stelo-has-been-cleared-by-the-fda-.html